Tokyo, June 16 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061912) titled 'Study on prediction of treatment response using fecal EDN in patients with inflammatory bowel disease' on June 15.
Study Type:
Observational
Primary Sponsor:
Institute - Shimane University Faculty of Medicine
Condition:
Condition - Inflammatory bowel disease (ulcerative colitis, Crohn's disease)
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The objective of this study is to prospectively evaluate whether serum and fecal eosinophil-derived neurotoxin (EDN), as well as the EDN/fecal calprotectin ratio, reflect disease activity, endoscopic activity, inflammatory ph...